Novo Nordisk A/S buy t66wv33c
Summary
This prediction ended on 10.10.16 with a price of €36.23. The price of Novo Nordisk A/S has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.97%. t66wv33c has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novo Nordisk A/S | - | - | - | - |
iShares Core DAX® | -1.816% | -2.419% | 12.070% | 14.356% |
iShares Nasdaq 100 | 4.333% | 8.073% | 32.493% | 59.393% |
iShares Nikkei 225® | 0.657% | 1.234% | 2.682% | 5.342% |
iShares S&P 500 | 2.968% | 4.613% | 26.496% | 49.719% |
Comments by t66wv33c for this prediction
In the thread Novo Nordisk A/S diskutieren
Das war zu viel abwärts
Hallo,
natürlich ist man beleidigt, denn die Dividende wurde ca. halbiert.
Jetzt ein Teileinstieg könnte eine günstige Gelegenheit sein.
Ex Dividemdentag ist der 11. Aug. Schon am 23. Aug. ist die Auszahlung.
Trotzdem sollte man Geduld mitbringen!
Alles in Allem war bisher Novo N. eine der defensivsten Aktien!